The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
ALS Therapy Development Institute
a/k/a: ALS TDI
300 Technology Sq, Suite 400
Cambridge, MA 02139
The ALS Therapy Development Institute (ALS TDI) is a non-profit organization whose mission is to develop effective therapeutics that slow or stop the progression of amyotrophic lateral sclerosis (ALS). Through the use of international ALS research databases, the ALS TDI lab evaluates and tests preclinical potential therapeutics, including small molecules, protein biologics, gene therapies and cell-based constructs. ALS TDI employs 30 professional scientists to conduct these studies. We collaborate with academia and industry to accelerate ALS therapeutic development. ALS is one of a group of diseases known as motor neuron diseases. It is characterized by progressive degeneration and eventual death of nerve cells in the brain, brainstem, and spinal cord that facilitate communication between the nervous system and voluntary muscles of the body.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.